We use cookies on our website. Carry on browsing if you’re happy with this or find out more



Productive partnerships

Creating novel therapeutics together

Open, collaborative, successful

Partnerships with pharmaceutical and biotechnology companies and academia are key drivers to realising our vision to become a commercial biopharmaceutical company with an innovative edge that will provide patients with transformational new medicines. Our strategy is based on an open and collaborative model, in which we combine our internal antibody discovery capabilities with partners possessing world-leading scientific and medical expertise and novel technological capabilities.

We discover and develop antibody therapeutics to build a strong portfolio of assets

View our pipeline